1-3 of 3
Victor Dong
Close
Sort by
Journal Articles

Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up

Clinical Trials & Observations
M. Domenica Cappellini, Mohamed Bejaoui, Leyla Agaoglu, Duran Canatan, Marcello Capra, Alan Cohen, Guillermo Drelichman, Marina Economou, Slaheddine Fattoum, Antonis Kattamis, Yurdanur Kilinc, Silverio Perrotta, Antonio Piga, John B. Porter, Louis Griffel, Victor Dong, Joan Clark, Yesim Aydinok
Journal: Blood
Blood (2011) 118 (4): 884–893.
https://doi.org/10.1182/blood-2010-11-316646
Published: 2011
Includes: Supplemental data
Journal Articles

Deferasirox Improves Liver Pathology In β-Thalassemia Patients with Transfusional Iron Overload

Yves Deugnier, MD, Bruno Turlin, MD, PhD, Victor Dong, MD, Vanessa Giannone, BSN, Yiyun Zhang, PhD, Louis Griffel, MD, Pierre Brissot, MD
Journal: Blood
Blood (2010) 116 (21): 4274.
https://doi.org/10.1182/blood.V116.21.4274.4274
Published: 2010
Journal Articles

Safety of Deferasirox (Exjade®) in Myelodysplastic Syndromes (MDS) and Non-MDS Patients with Transfusional Iron Overload: A Pooled Analysis Focusing On Renal Function.

Mathias Schmid, M. Domenica Cappellini, John B. Porter, Peter L. Greenberg, MD, Tomasz Lawniczek, Sabine Glaser, Victor Dong, Norbert Gattermann, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1768.
https://doi.org/10.1182/blood.V114.22.1768.1768
Published: 2009